|
HS Code |
495435 |
| Product Name | Deer Myocardial Peptide |
| Source | Deer heart tissue |
| Main Component | Bioactive peptides |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Purity | Typically over 90% |
| Molecular Weight Range | 200-3000 Da |
| Usage | Dietary supplement or research |
| Storage Conditions | Cool, dry place, away from direct sunlight |
| Form | Powder |
| Extraction Method | Enzymatic hydrolysis |
| Odor | Practically odorless |
| Intended Use | Human or animal supplementation |
| Shelf Life | 2-3 years if stored properly |
| Contraindications | Consult a healthcare provider before use |
As an accredited Deer Myocardial Peptide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for Deer Myocardial Peptide contains 10 vials (2mg each), securely sealed in a sterile, labeled white box. |
| Shipping | Deer Myocardial Peptide is shipped in secure, temperature-controlled packaging to maintain stability and purity. The product is typically dispatched via express courier with tracking, ensuring prompt and safe delivery. All shipments include appropriate labeling and documentation in compliance with international chemical transport regulations. |
| Storage | Deer Myocardial Peptide should be stored in a tightly sealed container at −20°C, protected from light and moisture. Avoid repeated freeze-thaw cycles to maintain peptide stability and bioactivity. For long-term storage, keep the peptide lyophilized and aliquot solutions after reconstitution. Store reconstituted solutions at −20°C and use promptly to preserve quality. |
| Purity 98%: Deer Myocardial Peptide with purity 98% is used in cardiovascular research, where it ensures high specificity in myocardial cell response assays. Molecular weight 1.2 kDa: Deer Myocardial Peptide with a molecular weight of 1.2 kDa is used in cell signaling studies, where it enables efficient cellular uptake and receptor binding. Stability at 4°C: Deer Myocardial Peptide with stability at 4°C is used in long-term biobank storage, where it maintains peptide integrity and bioactivity. Peptide content ≥90%: Deer Myocardial Peptide with peptide content ≥90% is used in pharmaceutical formulation, where it enhances consistency and potency in therapeutic development. Endotoxin level <1 EU/mg: Deer Myocardial Peptide with endotoxin level <1 EU/mg is used in in vivo animal studies, where it minimizes risk of adverse immunogenic reactions. Lyophilized powder form: Deer Myocardial Peptide in lyophilized powder form is used in peptide reconstitution protocols, where it allows precise dosing and ease of handling. Solubility in water ≥10 mg/mL: Deer Myocardial Peptide with solubility in water ≥10 mg/mL is used in injectable formulation preparation, where it provides homogenous and stable solutions. pH stability range 5.5–8.0: Deer Myocardial Peptide with pH stability range 5.5–8.0 is used in buffered cell culture experiments, where it preserves structural conformation and activity. Low ash content ≤2%: Deer Myocardial Peptide with low ash content ≤2% is used in analytical quality control, where it reduces inorganic impurities and enhances assay accuracy. Particle size <100 µm: Deer Myocardial Peptide with particle size <100 µm is used in suspension formulations, where it ensures uniform dispersion and predictable release kinetics. |
Competitive Deer Myocardial Peptide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In our experience as a manufacturer committed to animal peptide research, producing Deer Myocardial Peptide draws on years of dedicated refinement of hydrolysis methods and extraction techniques. Over time, consistent advances in biochemistry have transformed what was once a raw, inconsistent material into a dependable ingredient with predictable properties. Each production run draws from select, traceable source materials, secured through partnerships built around animal health standards and sustainable practices. As a result, the final peptide powder or solution demonstrates reliable quality and bioactivity.
Production teams handle raw deer myocardial tissue under controlled conditions. We process the fresh tissue with enzyme digestion, optimized pH, and temperature management, which helps break down cellular proteins into short-chain peptides without degrading their structure. This approach preserves the unique peptide sequences found in deer heart, sequences not observed in bovine or porcine preparations. Unlike some peptide manufacturers who rely on rapid chemical hydrolysis or bulk vegetable protein, these care-intensive methods result in a noticeably cleaner, more intact product.
Testing remains a core part of our process. Along the way, we monitor hydrolysis kinetics, confirm peptide chain lengths by HPLC, and measure amino acid composition for every lot. This batch-to-batch consistency stands in sharp contrast to generic peptide blends, which rarely offer the same traceability or analytical discipline.
We currently offer Deer Myocardial Peptide as a freeze-dried powder under model designation DMP-90, ordered in vacuum-sealed drums of 500 grams or 1 kilogram. The key metric here is purity—each batch consistently tests above 90 percent peptide content by HPLC, free from non-peptidic impurities. Moisture content stays below 5 percent, preventing caking and keeping the preparation stable without added preservatives.
Color ranges from off-white to pale tan, reflecting the natural origin and absence of any coloring agents. Texture remains fine-grained, dissolving easily in cold water, buffer, or cell culture media—a feature that matters for both R&D and larger-scale manufacturing users. Peptide chain length primarily falls under 1,800 Daltons, a range that supports good absorption and bioavailability in laboratory models. Analytical data are always issued with shipments, with free access to certificates of analysis upon request.
Deer Myocardial Peptide has found its place in a variety of applications. Some life science customers run assays with it to study its cell support functions or anti-inflammatory properties. In our discussions with researchers, many express interest in peptide fractions derived specifically from heart muscle tissue, since cardiac-origin peptides often differ in physiological activity from muscle-derived or systemic collagen peptides.
Others in the supplements industry formulate with Deer Myocardial Peptide because of its amino acid profile. Heart muscle provides a concentrated source of arginine, histidine, lysine, and branched-chain amino acids, which are essential for athletes and patients in recovery. Unlike peptides from bones or skin, myocardial peptides lack high levels of crosslinked collagen—a trait that supports easier digestion and absorption.
We regularly hear feedback about ease of blending. Unlike casein-derived peptides that can form stubborn clumps or gel, Deer Myocardial Peptide provides a neutral flavor profile and doesn't change the mouthfeel of finished products. This expands its utility in drink powders, bars, and even gummies, as well as medical nutrition products where smooth texture matters.
One theme stands out—reliability. Most of our business is with repeat partners, ranging from pharmaceutical suppliers running long-term studies to food producers interested in natural, functional peptides. We provide technical support and formulation advice well beyond shipment, based partly on research from our in-house lab and our connection to industrial consortia studying biologically active peptides world-wide.
Any peptide’s value depends not just on purity or origin, but also on biological relevance. Deer Myocardial Peptide distinguishes itself through its natural source, production transparency, and composition. Other animal peptides on the market, especially those based on bovine or porcine hearts, often use mixed tissue. This can introduce batch-related differences in bioactive sequences and result in higher immunogenicity for some consumers. Our facility uses tissue that is sourced exclusively from dedicated herds, focusing on traceability down to the animal and collection time.
Vegetal sources such as wheat, soy, or rice protein hydrolysates aim to deliver large batches at lower costs. These materials, though suitable for some uses, do not contain the same peptide sequences present in the myocardium. Their amino acid spectrum also lacks the high arginine and taurine content that deer heart naturally provides. While some manufacturers use these sources to reduce allergenicity, the final products often carry unwanted flavors or require more processing to mask bitterness.
Collagen peptides, made from skin or bone, present another point of comparison. Their primary value comes from glycine-rich content and support for connective tissue or skin health. They rarely offer the same cardiovascular-oriented peptides, and their molecular weights trend higher. Customers seeking small-molecule peptides with cellular signaling functions say they see different effects with myocardial peptides, especially on cell viability in assays.
Deer Myocardial Peptide also stands apart in terms of taste and solubility. Collagen hydrolysates from animal hides can carry an unmistakable gelatin odor or aftertaste. The enzyme-directed hydrolysis and extra purification steps used on Deer Myocardial Peptide help remove these flavors, so the finished material remains nearly neutral. Many supplement formulators switch to this ingredient to avoid flavor-masking steps or repeated microencapsulation.
Our approach to quality starts with the herds and their environment. Animal health monitoring is routine, and collection teams document each supply lot for veterinary checks, feed history, and animal age. Once raw tissue enters the processing facility, it goes through a series of pathogen checks, including PCR screening for major zoonotic agents. Enzymatic hydrolysis occurs in closed, monitored vessels, with regular pH and temperature monitoring to prevent spoilage and safeguard peptide integrity.
We run chemistry and microbiology labs in parallel, checking for common contaminants—heavy metals, allergens, and pathogenic microbes—well before product packaging. Each lot’s data feeds back to our tracking database, and we retain reference samples for re-testing. Peptide identity confirmation uses advanced HPLC-MS, and outside laboratories audit our results at scheduled intervals.
Some clients ask about regulatory compliance, often comparing documentation requirements between deer-derived peptides and bovine products. Because our peptide comes from non-ruminant animals raised outside of BSE risk zones, the regulatory pathway in many markets can be smoother. Even so, we maintain export documentation against global standards including ISO9001 and HACCP. This approach has helped our partners navigate ingredient approvals in Korea, Japan, and the EU.
Allergenicity concerns come up frequently, especially from users unfamiliar with deer-sourced ingredients. Unlike milk or soy protein hydrolysates, deer heart does not contain the major allergenic proteins. Our data from in-house lab and independent studies confirm low immunogenicity, making it suitable for sensitive product formulations.
Nutritional supplement makers see the value in Deer Myocardial Peptide beyond just its amino acid profile. In pilot studies run with collaborative labs, myocardial peptides support nitric oxide production, vasodilation, and anti-inflammatory response in cell cultures. While scientific understanding here is growing, early-stage data points to benefits that classic collagen or plant peptides fail to deliver. Some research partners report increased systemic absorption rates due to the small peptide size.
Pharmaceutical researchers and clinical nutrition developers come to us when seeking alternatives to synthetic growth factors and hormones. We have supported projects investigating myocardial peptide’s effects on cardiac regeneration and wound healing models. Our technical teams work closely with partner institutions to design protocols and interpret peptide mapping data, ensuring that the active elements survive from ingredient to finished product.
Food and beverage companies, particularly in the functional foods niche, leverage the ease of incorporation and flavor stability. Because our myocardial peptides do not gel or clump, customers use them in meal replacement shakes, energy drinks, and nutrition bars without stability issues. In contrast, some other animal peptides interfere with product texture or create visible particulates.
Pet nutrition and veterinary supplement manufacturers also weigh the advantages of deer origin. Our teams have supplied peptide-rich blends for research in working dogs’ muscle recovery and cardiac health using deer myocardial fractions, a clear point of differentiation from either fish or bovine-based products that risk triggering dietary intolerances in some breeds.
Much of our product identity rests on ethical sourcing. Deer supply chains benefit from managed pasture rotation and sustainable animal care, and we commit to full traceability for every shipment. Our veterinary teams oversee animal health and husbandry, working with producers who understand the central role of welfare and environmental stewardship.
We track sourcing data, including feed inputs, animal age, and location. Processing waste is minimized by using offcuts and byproducts for energy recovery or pet feed, not landfilling. Water and energy management systems in the production plant reduce environmental impact by recycling process water and capturing excess heat for other plant operations.
Regular audits check adherence to these standards. Downstream partners request this information, which we provide openly to support third-party certifications and customer sustainability pledges.
Producing a premium animal-derived peptide brings several challenges. Reliable, high-quality tissue supply can fluctuate, especially during disease outbreaks or supply chain disruptions, but longstanding relationships with partner farms have helped us manage these risks. Supply agreements stress both biosecurity and flexibility, so we can provide continuous support to clinical and R&D projects.
As demand for clean-label ingredients grows, we continue to refine our production. Some customers ask for further reductions in processing aids or seek entirely enzyme-only hydrolysis. Our team has already phased out non-essential additives and works to offer an organic-certified peptide in the coming years, pending supply chain adaptation.
Batch-to-batch traceability and transparency will only gain in importance. Our IT systems map product movement from raw material to packaged peptide, an approach that exceeds government requirements and provides peace of mind for sensitive end-users.
Scientific research into myocardial bioactive peptides is ongoing. We continue collaborating with clinical research partners to document functional benefits of Deer Myocardial Peptide in new health areas—from post-surgery recovery to age-related cardiac support. Peer-reviewed results and new application studies will inform future production methods and give customers a stronger foundation for novel product development.
Customers working with us know the difference between supplier relationships. Many started out with trial orders or custom sample runs. In every case, direct discussions with our process team tailored the product for project needs, whether that meant adjusting solubility, modifying peptide lengths, or improving flavor neutrality.
Every order comes with technical background support. Teams include biochemists with industry and academic experience. They troubleshoot formulation challenges or explain technical data, creating a partnership that goes far beyond mere transaction. Our scale allows for custom batch sizes and technical consultancy at no additional charge, reflecting a focus on customer outcome, not just sales.
We genuinely want manufacturers, researchers, and food technologists to succeed using deer-derived peptides. Our own knowledge grows with every project—new analytics, shared research, even feedback from product failures improves what we do. If a partner encounters a processing issue or detects an unexpected result, we provide technical review, which sometimes means re-running in-house tests or reviewing process logs to track down the source.
Such openness to feedback and continual improvement guides our production philosophy, reflecting a genuine belief in the product's value and our responsibility to the industries relying on these high-grade animal peptides.
In this industry, long-term trust comes from steady, transparent relationships and products that meet real-world requirements. Deer Myocardial Peptide comes out of an experienced manufacturing process that has evolved with modern science and ethical sourcing. Whether used in health research, supplements, functional foods, or animal nutrition, it's not just another peptide powder—it's the result of years of expertise and ongoing partnership with our clients.
We see Deer Myocardial Peptide not as a commodity, but as a versatile, science-driven ingredient that adapts to changing needs, rigorous quality demands, and expectations for clean sourcing. Our commitment to continual improvement, technical support, and transparency shapes every batch we produce, and real progress in health and nutrition starts with such steadfast manufacturing principles.